Investments (#)


    DISCLAIMER: This chart is based on a limited amount of data and may change once additional information has been added. We are working hard to ensure the completeness of the data. If you want to assist us in our work, please contact us using this form.


    DISCLAIMER: This chart is based on a limited amount of data and may change once additional information has been added. We are working hard to ensure the completeness of the data. If you want to assist us in our work, please contact us using this form.

    Recent transactions in the domain of cirrhosis

    Country Funding round Date
    Versantis AG
    Lifesaving liver disease medicines.
    Switzerland Acquisition
    2022
    Versantis AG
    Lifesaving liver disease medicines.
    Switzerland N/A
    Versantis AG
    Lifesaving liver disease medicines.
    Switzerland N/A
    Versantis AG
    Lifesaving liver disease medicines.
    Switzerland N/A
    Versantis AG
    Lifesaving liver disease medicines.
    Switzerland N/A
    Versantis AG
    Lifesaving liver disease medicines.
    Switzerland N/A

    Best funded companies in cirrhosis





    Lifesaving liver disease medicines.

    Investment themes:

    Top investors in the domain of cirrhosis

    Profile Country Investments
    Healthequity Inc United States 1
    Verve Capital Partners AG Switzerland 1
    Esperante Ventures 1
    Zurich Cantonal Bank Switzerland 1
    Redalpine Venture Partners AG Seed and early-stage venture capital firm investing in disruptive technologies with focus on highly scalable ICT and Health Tech models. Switzerland 1
    Swisscanto Asset Management International SA 1

    Top acquirers in the domain of cirrhosis

    Profile Country Acquisitions
    GENFIT SA 1